Akron Pharma Inc is a privately held pharmaceutical company focusing on developing and marketing generic products. The company operates as an own label distributor, conducting pharmaceutical research, development, and marketing in the U.S. market, offering a broad range of generic prescription products across various dosage forms and therapeutic categories. Akron Pharma Inc has a fully integrated manufacturing network, ranging from API to finished formulation, to drive profitability and extend affordability to the customer. The AKRON label is well-recognized by various entities within the healthcare industry, such as retail pharmacy chains, mail-order pharmacies, pharmacy benefit managers, managed care facilities, group purchasing organizations, wholesalers, and distributors throughout the United States. The company's mission revolves around the belief that lower-cost generic medication enhances patient access and offsets overall healthcare costs. Akron Pharma Inc aims to make a difference by developing, manufacturing, and commercializing quality generic medications as cost-effective solutions for patients, suppliers, and stakeholders across the healthcare continuum. Their products are designed to improve access, safety, quality, and transparency standards, aligning with their slogan, "Make It Available and Make It Affordable." As of now, there is no publicly available information about the last investment, investors, founding date, or headquarters of Akron Pharma Inc. The company operates within the pharmaceutical industry, catering to the growing demand for generic medication solutions.
There is no investment information
No recent news or press coverage available for Akron Pharma Inc.